Graham Ruecroft

736 total citations
15 papers, 555 citations indexed

About

Graham Ruecroft is a scholar working on Molecular Biology, Organic Chemistry and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Graham Ruecroft has authored 15 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Organic Chemistry and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Graham Ruecroft's work include Enzyme Catalysis and Immobilization (4 papers), Biochemical and Molecular Research (4 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Graham Ruecroft is often cited by papers focused on Enzyme Catalysis and Immobilization (4 papers), Biochemical and Molecular Research (4 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Graham Ruecroft collaborates with scholars based in United Kingdom and United States. Graham Ruecroft's co-authors include Tuan Q. Ly, Peter W. Cains, Raymond McCague, Robert Price, Jagdeep Shur, Stephen J. Taylor, Stanley M. Roberts, Richard Wisdom, Carol Lee and Jennifer A. Littlechild and has published in prestigious journals such as International Journal of Pharmaceutics, Biochemical Pharmacology and Pharmaceutical Research.

In The Last Decade

Graham Ruecroft

14 papers receiving 523 citations

Peers

Graham Ruecroft
Koustuv Chatterjee United States
Cletus Nunes United States
M. J. Wilkins United Kingdom
Patricia Darcy United Kingdom
Abira Pyne United States
Steven W. Booth United Kingdom
Koustuv Chatterjee United States
Graham Ruecroft
Citations per year, relative to Graham Ruecroft Graham Ruecroft (= 1×) peers Koustuv Chatterjee

Countries citing papers authored by Graham Ruecroft

Since Specialization
Citations

This map shows the geographic impact of Graham Ruecroft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham Ruecroft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham Ruecroft more than expected).

Fields of papers citing papers by Graham Ruecroft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graham Ruecroft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham Ruecroft. The network helps show where Graham Ruecroft may publish in the future.

Co-authorship network of co-authors of Graham Ruecroft

This figure shows the co-authorship network connecting the top 25 collaborators of Graham Ruecroft. A scholar is included among the top collaborators of Graham Ruecroft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graham Ruecroft. Graham Ruecroft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Shur, Jagdeep, et al.. (2012). Influence of crystal form of ipratropium bromide on micronisation and aerosolisation behaviour in dry powder inhaler formulations. Journal of Pharmacy and Pharmacology. 64(9). 1326–1336. 9 indexed citations
2.
Shur, Jagdeep, et al.. (2012). Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation. International Journal of Pharmaceutics. 430(1-2). 26–33. 21 indexed citations
4.
Ruecroft, Graham. (2007). Ultrasound, crystallisation & drug formulation. 27(5). 60–62. 2 indexed citations
5.
Bergeron, Sophie, et al.. (2006). Nitrilase-Catalysed Desymmetrisation of 3-Hydroxyglutaronitrile:  Preparation of a Statin Side-Chain Intermediate. Organic Process Research & Development. 10(3). 661–665. 57 indexed citations
6.
Ruecroft, Graham, et al.. (2006). Immobilization of Cholesterol Esterase for Use in Multiple Batch Biotransformations to Prepare (−)- FTC (Emtricitabine). Organic Process Research & Development. 10(3). 670–672. 7 indexed citations
7.
Ruecroft, Graham, et al.. (2005). Sonocrystallization:  The Use of Ultrasound for Improved Industrial Crystallization. Organic Process Research & Development. 9(6). 923–932. 308 indexed citations
8.
Boulton, Lee T., Martin E. Fox, Mark Jackson, et al.. (2002). Synthesis of the Potent Antiglaucoma Agent, Travoprost. Organic Process Research & Development. 6(2). 138–145. 24 indexed citations
9.
Hanson, Chris, et al.. (1997). Process Research and Development for the Production of Intermediates for the Synthesis of Carbocyclic Nucleosides. Organic Process Research & Development. 1(6). 415–419. 3 indexed citations
10.
Holt, Karen, et al.. (1997). A short, scaleable synthesis of both enantiomers of 2-benzoylsulfanyl-5-phthalimidopentanoic acid from ornithine. Tetrahedron Letters. 38(47). 8253–8256. 1 indexed citations
11.
McCague, Raymond, et al.. (1996). Unexpected stereoselectivity in the cis dihydroxylation of some 2-cyclopentene-1-carboxamides. Tetrahedron Letters. 37(26). 4601–4604. 11 indexed citations
12.
Taylor, Stephen J., Raymond McCague, Richard Wisdom, et al.. (1993). Development of the biocatalytic resolution of 2-azabicyclo[2.2.1]hept-5-en-3-one as an entry to single-enantiomer carbocyclic nucleosides. Tetrahedron Asymmetry. 4(6). 1117–1128. 80 indexed citations
14.
Iley, Jim & Graham Ruecroft. (1990). Mechanism of the microsomal demethylation of 1-aryl-3,3-dimethyltriazenes. Biochemical Pharmacology. 40(9). 2123–2128. 4 indexed citations
15.
Moreira, Rui, et al.. (1988). Synthesis of S-cysteinyl, S(N-acetylcysteinyl) and S-glutathionyl conjugates op N-hydroxymethyltriazenes. Tetrahedron Letters. 29(22). 2707–2710. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026